Skip to main content
Hualan Biological Engineering Inc. logo

Hualan Biological Engineering Inc. — Investor Relations & Filings

Ticker · 002007 ISIN · CNE000001JN8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,526 across all filing types
Latest filing 2021-07-22 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002007

About Hualan Biological Engineering Inc.

https://www.hualanbio.com

Hualan Biological Engineering Inc. is a biopharmaceutical enterprise specializing in the research, development, production, and commercialization of blood products and vaccines. The company’s portfolio is divided into two primary segments: plasma-derived therapeutics and viral vaccines. Key blood products include human albumin, intravenous immunoglobulin (IVIG), human coagulation factor VIII, and prothrombin complex. In the vaccine sector, the company produces seasonal influenza vaccines, including quadrivalent formulations, as well as hepatitis B and rabies vaccines. Hualan Biological Engineering operates advanced manufacturing facilities and plasma collection centers, focusing on high-quality standards and technological innovation in recombinant protein drugs and monoclonal antibodies to address critical medical needs in immunology, hematology, and infectious disease prevention.

Recent filings

Filing Released Lang Actions
关于受暴雨灾害影响的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (508 characters) from a company about the impact of a recent natural disaster (heavy rain and flooding) on its operations. It states the situation, emergency response, and expected impact on business performance. There is no financial data, no detailed report, no voting results, no management changes, no legal proceedings, no capital changes, and no mention of any report publication. The document is a regulatory announcement informing investors about a material event affecting the company. Given the short length and content, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-07-22 Chinese
2020年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is titled as an announcement regarding the implementation of the 2020 annual equity distribution (dividend) plan by 华兰生物工程股份有限公司. It details the dividend amount per share, the approval by the 2020 Annual General Meeting (AGM), the record date, ex-dividend date, and the method of dividend distribution. The document does not contain full financial statements or comprehensive financial performance data but focuses solely on the dividend distribution details. It is not a full Annual Report (10-K) or Interim Report (IR), nor is it a proxy solicitation or voting results announcement. Given the content and length (1761 characters), this is a Notice of Dividend Amount (DIV) filing, which announces dividend amounts, payment dates, and related details to shareholders.
2021-06-15 Chinese
关于参加河南辖区上市公司2021年投资者网上集体接待日活动的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (453 characters) about the company's participation in an investor online reception day event. It includes details about the event date, time, and participants but does not contain any financial data, report content, or voting results. It is not a report itself but an announcement related to investor relations activities. Given the content and length, it fits best as a Regulatory Filing (RNS), which is the fallback category for miscellaneous announcements that do not fit other specific categories.
2021-06-02 Chinese
关于2018年限制性股票激励计划首次授予的第二期限制性股票解锁上市流通的提示性公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding the unlocking and listing of restricted shares under a 2018 restricted stock incentive plan. It includes information about board and supervisory approvals, legal opinions, conditions for unlocking, and shareholding changes. The content focuses on the company's stock incentive plan execution and related share unlock events, not on financial results, earnings, or annual reports. It is not a full financial report but a regulatory announcement about share unlocking and stock incentive plan progress. This fits best under Regulatory Filings (RNS) as it is a compliance and disclosure document related to share incentive plans and share unlocks, not a direct financial report or capital change announcement like SHA or POS, since it does not announce new share issuance or buybacks but the unlocking of previously granted restricted shares under an incentive plan.
2021-05-10 Chinese
一季报监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Hualan Biological Engineering Co., Ltd. It includes the approval of the 2021 first quarter report and confirms the legality and accuracy of the report. The document is relatively short (802 characters) and primarily serves as an announcement of the approval and review of the quarterly report rather than the report itself. It does not contain the full financial statements or substantive financial data but certifies the report's compliance and accuracy. Therefore, it is best classified as a Regulatory Filing (RNS) rather than an Interim/Quarterly Report (IR).
2021-04-29 Chinese
安徽承义律师事务所关于华兰生物工程股份有限公司召开2020年度股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening and proceedings of the 2020 Annual General Meeting (AGM) of 华兰生物工程股份有限公司. It details the legality of the meeting's convening, the qualifications of attendees, the proposals considered, and the voting results. The document does not contain the actual annual report or financial statements but rather confirms the validity and legality of the AGM and its resolutions. The document length is 3633 characters, which is relatively short and consistent with a legal opinion or voting results announcement rather than a full report. Therefore, this document fits best into the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2021-04-29 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.